Causal Relationship Between Matrix Metalloproteinase with Their Tissue Inhibitors and Human Immunodeficiency Virus Infection: A Two-Sample Bidirectional Mendelian Randomization Analysis.

IF 1.1 4区 医学 Q4 IMMUNOLOGY
Chao Guo, Yushan Zhang, Xiujuan Li, Yujing Duan
{"title":"Causal Relationship Between Matrix Metalloproteinase with Their Tissue Inhibitors and Human Immunodeficiency Virus Infection: A Two-Sample Bidirectional Mendelian Randomization Analysis.","authors":"Chao Guo, Yushan Zhang, Xiujuan Li, Yujing Duan","doi":"10.1177/08892229251359534","DOIUrl":null,"url":null,"abstract":"<p><p>Studies have shown an association between matrix metalloproteinases (MMPs) along with tissue inhibitors of MMPs (TIMP) and human immunodeficiency virus (HIV) infection and CD4<sup>+</sup> T cell count, a key clinical indicator for HIV progression, but the causality remains unclear. This study aimed to investigate the bidirectional causal relationship between MMPs/TIMP and HIV. A genome-wide association study-based two-sample bidirectional Mendelian randomization (MR) analysis was conducted to elucidate the potential causal links between MMPs/TIMP and HIV. This approach utilized robust estimators, including inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode. Furthermore, sensitivity analyses including Cochran's Q, MR-Egger, leave-one-out, and MR pleiotropy residual sum and outlier (MR-PRESSO) tests were employed to assess heterogeneity and pleiotropic effects. The IVW analysis in the forward MR study indicated that genetically predicted levels of MMP-3 [odds ratio or OR (95% confidence interval or CI) = 0.69 (0.47-1), <i>p</i> = .047], MMP-20 [OR (95% CI) = 0.64 (0.43-0.97), <i>p</i> = .035], and TIMP-2 [OR (95% CI) = 0.68 (0.47-0.97), <i>p</i> = .034] were potentially associated with a lower risk of HIV. MMP-13 exhibited a genetically predicted association with a higher risk of HIV [OR (95% CI) = 2 (1.17-3.41), <i>p</i> = .011]. Additionally, MMP-19 demonstrated a genetic association with CD4<sup>+</sup> T cell absolute count [OR (95% CI) = 0.90 (0.81-1.00), <i>p</i> = .042). The reverse MR analysis indicated that genetically predicted liability to HIV was associated with a higher level of MMP-1 [OR (95% CI) = 1.04 (1.01-1.08), <i>p</i> = .024]. Heterogeneity and horizontal pleiotropy were found between MMP-9 and HIV by Cochran's Q test and MR-Egger, but MR-PRESSO indicated no outliers. This study revealed a complex MMPs-TIMPs interplay influencing HIV risk. Future research should clarify underlying mechanisms.</p>","PeriodicalId":7544,"journal":{"name":"AIDS research and human retroviruses","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS research and human retroviruses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08892229251359534","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Studies have shown an association between matrix metalloproteinases (MMPs) along with tissue inhibitors of MMPs (TIMP) and human immunodeficiency virus (HIV) infection and CD4+ T cell count, a key clinical indicator for HIV progression, but the causality remains unclear. This study aimed to investigate the bidirectional causal relationship between MMPs/TIMP and HIV. A genome-wide association study-based two-sample bidirectional Mendelian randomization (MR) analysis was conducted to elucidate the potential causal links between MMPs/TIMP and HIV. This approach utilized robust estimators, including inverse variance weighted (IVW), MR-Egger, weighted median, and weighted mode. Furthermore, sensitivity analyses including Cochran's Q, MR-Egger, leave-one-out, and MR pleiotropy residual sum and outlier (MR-PRESSO) tests were employed to assess heterogeneity and pleiotropic effects. The IVW analysis in the forward MR study indicated that genetically predicted levels of MMP-3 [odds ratio or OR (95% confidence interval or CI) = 0.69 (0.47-1), p = .047], MMP-20 [OR (95% CI) = 0.64 (0.43-0.97), p = .035], and TIMP-2 [OR (95% CI) = 0.68 (0.47-0.97), p = .034] were potentially associated with a lower risk of HIV. MMP-13 exhibited a genetically predicted association with a higher risk of HIV [OR (95% CI) = 2 (1.17-3.41), p = .011]. Additionally, MMP-19 demonstrated a genetic association with CD4+ T cell absolute count [OR (95% CI) = 0.90 (0.81-1.00), p = .042). The reverse MR analysis indicated that genetically predicted liability to HIV was associated with a higher level of MMP-1 [OR (95% CI) = 1.04 (1.01-1.08), p = .024]. Heterogeneity and horizontal pleiotropy were found between MMP-9 and HIV by Cochran's Q test and MR-Egger, but MR-PRESSO indicated no outliers. This study revealed a complex MMPs-TIMPs interplay influencing HIV risk. Future research should clarify underlying mechanisms.

基质金属蛋白酶及其组织抑制剂与人类免疫缺陷病毒感染的因果关系:双样本双向孟德尔随机分析。
研究表明基质金属蛋白酶(MMPs)和组织抑制剂(TIMP)与人类免疫缺陷病毒(HIV)感染和CD4+ T细胞计数之间存在关联,CD4+ T细胞计数是HIV进展的关键临床指标,但因果关系尚不清楚。本研究旨在探讨MMPs/TIMP与HIV之间的双向因果关系。一项基于双样本双向孟德尔随机化(MR)分析的全基因组关联研究旨在阐明MMPs/TIMP与HIV之间的潜在因果关系。该方法利用了稳健估计量,包括逆方差加权(IVW)、MR-Egger、加权中位数和加权模式。此外,采用Cochran’s Q、MR- egger、leave-one-out和MR多效性残差和异常值(MR- presso)检验等敏感性分析来评估异质性和多效性效应。前瞻性MR研究中的IVW分析表明,基因预测的MMP-3水平[比值比或or(95%置信区间或CI) = 0.69 (0.47-1), p = 0.047], MMP-20 [or (95% CI) = 0.64 (0.43-0.97), p = 0.035]和TIMP-2 [or (95% CI) = 0.68 (0.47-0.97), p = 0.034]与较低的HIV风险潜在相关。MMP-13表现出与HIV高风险的遗传预测相关性[OR (95% CI) = 2 (1.17-3.41), p = 0.011]。此外,MMP-19显示出与CD4+ T细胞绝对计数的遗传关联[OR (95% CI) = 0.90 (0.81-1.00), p = 0.042)。反向MR分析表明,基因预测的HIV易感性与较高水平的MMP-1相关[OR (95% CI) = 1.04 (1.01-1.08), p = 0.024]。Cochran’s Q检验和MR-Egger检测发现MMP-9与HIV之间存在异质性和水平多效性,但MR-PRESSO未发现异常值。这项研究揭示了一个复杂的mmp - timps相互作用影响HIV风险。未来的研究应阐明潜在的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
6.70%
发文量
201
审稿时长
3-6 weeks
期刊介绍: AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes. AIDS Research and Human Retroviruses coverage includes: HIV cure research HIV prevention science - Vaccine research - Systemic and Topical PreP Molecular and cell biology of HIV and SIV Developments in HIV pathogenesis and comorbidities Molecular biology, immunology, and epidemiology of HTLV Pharmacology of HIV therapy Social and behavioral science Rapid publication of emerging sequence information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信